Mallinckrodt Pharmaceuticals
Mallinckrodt, which has its headquarters in Mulhuddart, Dublin 15 but operates from its location in Missouri in the US, is a global specialty biopharmaceutical and medical imaging business that develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. Mallinckrodt was spun-off by Covidien in 2013.
Financial Data
-
28th Dec 18 Source: CRO
- €2.9 billion turnover
-
-€3.6 billion
profit - 3,517 employees
-
29th Dec 17 Source: Company
- €3.3 billion turnover
-
-€135 million
profit - 4,089 employees
- 2 more years available »
Ranking
By Turnover
(€2.9 billion)- 38th in Top Companies
By Employees
(3,517)- 67th in Top Companies
- 3,517
- €2.9 billion
Employees
- David Keenan Vice President}
Latest News
- 11:16am European markets stabilise after coronavirus hit
- 10:09am Companies shutting locations in China over coronavirus
- 8:27am Facebook rolls out tools to restrict data gathering on users
- 8:04am Good strat for UDG as company reports quarterly profits ahead of 2019
- 8:04am Good start for UDG as company reports quarterly profits ahead of 2019